Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Aadi Bioscience
(NASDAQ:AADI)
Intraday
$1.7494
0.0694
[4.13%]
After-Hours
$1.7494
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.7494
0.0694
[4.13%]
At close: Apr 26
$1.7494
0
[0.00%]
After Hours: 4:37PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Aadi Bioscience Stock (NASDAQ:AADI)
Aadi Bioscience Stock (NASDAQ: AADI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 18, 2024
Reported Sunday, Aadi Bioscience Presented New Subgroup Analysis Of Patients With Advanced Malignant PEComa Of Gynecologic Origin Treated With nab-Sirolimus At Society Of Gynecologic Oncology
Benzinga Newsdesk
-
Mar 18, 2024, 2:24AM
Wednesday, March 13, 2024
Aadi Bioscience shares are trading higher after the company reported better-than-expected Q4 financial results.
Benzinga Newsdesk
-
Mar 13, 2024, 3:33PM
Aadi Bioscience's Cash, Cash Equivalents And Short-term Investments As Of December 31, 2023, Is Expected To Fund Operations Into Q4 2025 Based On Current Plans
Benzinga Newsdesk
-
Mar 13, 2024, 8:03AM
Aadi Bioscience Q4 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $6.33M Beat $6.29M Estimate
Benzinga Newsdesk
-
Mar 13, 2024, 8:02AM
Earnings Scheduled For March 13, 2024
Benzinga Insights
-
Mar 13, 2024, 6:15AM
Tuesday, March 12, 2024
Aadi Bioscience Earnings Preview
Benzinga Insights
-
Mar 12, 2024, 1:01PM
Monday, March 04, 2024
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 4, 2024, 1:29PM
Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 4, 2024, 8:04AM
Friday, March 01, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Mar 1, 2024, 4:32PM
Aadi Bioscience Announces Publication Of Long-Term Efficacy And Safety Data Further Supporting FYARRO For The Treatment Of Malignant PEComa
Benzinga Newsdesk
-
Mar 1, 2024, 4:14PM
Friday, January 26, 2024
Aadi Bioscience Announces Poster Presentations At The 2024 American Society Of Clinical Oncology Genitourinary Cancers Symposium
Benzinga Newsdesk
-
Jan 26, 2024, 4:08PM
Monday, December 18, 2023
Top 3 Health Care Stocks That Are Preparing To Pump This Month
Avi Kapoor
-
Dec 18, 2023, 7:39AM
Friday, December 15, 2023
Cancer Player Aadi Bioscience Downgraded: Analyst Highlights 'Worse Than Expected' Response Rates
Vandana Singh
-
Dec 15, 2023, 2:16PM
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Dec 15, 2023, 12:46PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 15, 2023, 12:31PM
Dow Edges Higher; Darden Restaurants Earnings Top Views
Avi Kapoor
-
Dec 15, 2023, 12:25PM
Piper Sandler Maintains Overweight on Aadi Bioscience, Lowers Price Target to $5
Benzinga Newsdesk
-
Dec 15, 2023, 12:15PM
US Stocks Mixed; Costco Posts Upbeat Earnings
Avi Kapoor
-
Dec 15, 2023, 9:41AM
Why Is Anti-Cancer Focused Aadi Bioscience Stock Trading Lower Today?
Vandana Singh
-
Dec 15, 2023, 9:15AM
Aadi Bioscience shares are trading lower after the company reported interim results from the PRECISION1 trial of nab-sirolimus.
Benzinga Newsdesk
-
Dec 15, 2023, 9:01AM
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 15, 2023, 8:17AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 15, 2023, 8:08AM
HC Wainwright & Co. Downgrades Aadi Bioscience to Neutral
Benzinga Newsdesk
-
Dec 15, 2023, 6:32AM
Thursday, December 14, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 14, 2023, 4:31PM
Aadi Bioscience Reports Interim Results From PRECISION1 Trial Of Nab-Sirolimus Demonstrating Anti-Tumor Activity In Solid Tumors With TSC1 Or TSC2 Inactivating Alterations
Benzinga Newsdesk
-
Dec 14, 2023, 4:05PM
Monday, November 13, 2023
HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36
Benzinga Newsdesk
-
Nov 13, 2023, 6:15PM
Wednesday, November 08, 2023
Aadi Bioscience Q3 EPS $(0.60) Vs $(0.68) Prior Year, Sales $5.96M Miss $6.61M Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 8:02AM
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Tuesday, November 07, 2023
Preview: Aadi Bioscience's Earnings
Benzinga Insights
-
Nov 7, 2023, 3:01PM
Friday, November 03, 2023
Executive Chairman of Aadi Bioscience Sold $185K In Stock
Benzinga Insights
-
Nov 3, 2023, 11:01AM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Executive Chairman of Aadi Bioscience Sold $179K In Stock
Benzinga Insights
-
Oct 4, 2023, 11:01AM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 2, 2023, 1:00PM
Aadi Bioscience Appoints Dave Lennon, As President and Chief Executive Officer
Benzinga Newsdesk
-
Oct 2, 2023, 8:03AM
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 29, 2023, 2:09PM
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 21, 2023, 12:08PM
Thursday, September 07, 2023
Executive Chairman At This Health Care Company Sells $238K of Stock
Benzinga Insights
-
Sep 7, 2023, 11:01AM
Thursday, August 10, 2023
HC Wainwright & Co. Reiterates Buy on Aadi Bioscience, Maintains $45 Price Target
Benzinga Newsdesk
-
Aug 10, 2023, 7:41AM
Wednesday, August 09, 2023
Aadi Bioscience Expands Pipeline To Include Endometrial Cancer and Neuroendocrine Tumors (NETs) Programs
Benzinga Newsdesk
-
Aug 9, 2023, 8:06AM
Aadi Bioscience Q2 EPS $(0.67) Misses $(0.62) Estimate, Sales $6.20M Beat $6.20M Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 8:04AM
Earnings Scheduled For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 4:54AM
Tuesday, August 08, 2023
Earnings Preview: Aadi Bioscience
Benzinga Insights
-
Aug 8, 2023, 2:01PM
Tuesday, August 01, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 1, 2023, 3:06PM
Friday, July 28, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Jul 28, 2023, 12:36PM
Tuesday, July 18, 2023
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Lisa Levin
-
Jul 18, 2023, 8:54AM
Friday, July 07, 2023
Aadi Bioscience Insider Trades Send a Signal
Benzinga Insights
-
Jul 7, 2023, 11:02AM
Thursday, July 06, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Jul 6, 2023, 12:58PM
Wednesday, July 05, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Jul 5, 2023, 12:43PM
Wednesday, June 21, 2023
Aadi Bioscience Director Awarded $221K Worth of Stock Options
Benzinga Insights
-
Jun 21, 2023, 11:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch